Clinical trial
Trial of Iseganan in Prevention of Ventilator-Associated Pneumonia
NCT00118781 · IntraBiotics Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00118781 |
|---|---|
| Title | Trial of Iseganan in Prevention of Ventilator-Associated Pneumonia |
| Official title | Randomized, Double-Blind, Placebo-Controlled, Multinational Phase 3 Trial Of Iseganan In Prevention Of Ventilator-Associated Pneumonia |
| Lead sponsor | IntraBiotics Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Pneumonia |
| Intervention type | Drug |
| Interventions | iseganan hydrochloride |
| Enrollment | 900 |
| Start date | Sep 1, 2003 |
| Completion | Jun 1, 2004 |
| First posted | Jul 12, 2005 |
| Last update posted | Jul 19, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: